HER-2/NEU AMPLIFICATION IN FINE NEEDLE ASPIRATES FROM PRIMARY BREAST CANCER: IS IT A PREDICTIVE MARKER IN PATIENTS TREATED WITH NEO-ADJUVANT ANTHRACYCLINE-BASED CHEMOTHERAPY?

被引：0
|
作者：
Bozzetti, Cecilia [1 ]
Musolino, Antonino [1 ]
Personeni, Nicola [1 ]
Nizzoli, Rita [1 ]
Michiara, Maria [1 ]
Di Blasio, Beatrice [1 ]
Ceci, Guido [1 ]
Camisa, Roberta [1 ]
Cascinu, Stefano [2 ]
Ardizzoni, Andrea [1 ]
机构：
[1] Univ Hosp, Med Oncol Unit, Parma, Italy
[2] Le Torrette Hosp, Med Oncol Unit, Ancona, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [21] Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors
    M Hauglid Flågeng
    L L Haugan Moi
    J M Dixon
    J Geisler
    E A Lien
    W R Miller
    P E Lønning
    G Mellgren
    British Journal of Cancer, 2009, 101 : 1253 - 1260
  • [22] Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors
    Flageng, M. Hauglid
    Moi, L. L. Haugan
    Dixon, J. M.
    Geisler, J.
    Lien, E. A.
    Miller, W. R.
    Lonning, P. E.
    Mellgren, G.
    BRITISH JOURNAL OF CANCER, 2009, 101 (08) : 1253 - 1260
  • [23] Benefits of dexrazoxane in female patients with stage II breast cancer treated with anthracycline-based adjuvant chemotherapy
    Schnirer, I. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Predictive role molecular subtypes of cyclooxygenase-2 in basal-like breast cancer patients treated with adjuvant anthracycline-based chemotherapy
    Melucci, Elisa
    CELLULAR ONCOLOGY, 2008, 30 (02) : 157 - 158
  • [25] Topoisomerase IIα gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer:: Scandinavian Breast Group Trial 9401
    Tanner, Minna
    Isola, Jorma
    Wiklund, Tom
    Erikstein, Bjorn
    Kellokumpu-Lehtinen, Pirkko
    Malmstrom, Per
    Wilking, Nils
    Nilsson, Jonas
    Bergh, Jonas
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (16) : 2428 - 2436
  • [26] Determination Of HER-2 Gene Amplification By Chromogenic In-Situ Hybridization (CISH) On Fine Needle Aspirates From Primary And Metastatic Breast Carcinoma
    Almeida, Margarida M.
    Correia, Lurdes
    CANCER CYTOPATHOLOGY, 2008, 114 (05): : 447 - 447
  • [27] Anthracycline based chemotherapy decreases amplification status of Her-2/neu and topoisomerase II alpha genes in locally advanced breast cancer.
    Hajduch, M
    Palacova, M
    Trojanec, R
    Dusek, L
    Petrakova, K
    Spackova, K
    Obermannova, R
    Galova, M
    Blazkova, S
    Vyzula, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 840S - 840S
  • [28] Prognostic and predictive impact of the HER-2/neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer
    Müller, V
    Witzel, I
    Lück, HJ
    Köhler, G
    von Minckwitz, G
    Möbus, V
    Sattler, D
    Wilczak, W
    Löning, T
    Jänicke, F
    Pantel, K
    Thomssen, C
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 86 (01) : 9 - 18
  • [29] Prognostic and Predictive Impact of the HER-2/neu Extracellular Domain (ECD) in the Serum of Patients Treated with Chemotherapy for Metastatic Breast Cancer
    Volkmar Müller
    Isabell Witzel
    Hans Joachim Lück
    Günter Köhler
    Gunther von Minckwitz
    Volker Möbus
    Daniel Sattler
    Waldemar Wilczak
    Thomas Löning
    Fritz Jänicke
    Klaus Pantel
    Christoph Thomssen
    Breast Cancer Research and Treatment, 2004, 86 : 9 - 18
  • [30] The topoisomerase II alpha gene status in primary breast cancer is a predictive marker of the response to anthracycline-based neoadjuvant chemotherapy
    Kawachi, Kae
    Sasaki, Takeshi
    Murakami, Ayumi
    Ishikawa, Takashi
    Kito, Ayako
    Ota, Ikuko
    Shimizu, Daisuke
    Nozawa, Akinori
    Nagashima, Yoji
    Machinami, Rikuo
    Aoki, Ichiro
    PATHOLOGY RESEARCH AND PRACTICE, 2010, 206 (03) : 156 - 162
12345